Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
This is a critical governance and safety scenario. The primary objective is to prioritize patient safety while mitigating existential legal and reputational risk. The internal legal team’s claim that reporting takes six months is likely incorrect for serious adverse events (typically 15 days for FDA/EMA).Read the full answer
As CEO, my overriding duty is to balance patient safety, legal/regulatory compliance, fiduciary responsibility, and long-term corporate survival. A 1-in-8,000 risk of liver failure is rare but severe, potentially fatal, and materially unexpected relative to the current label.Read the full answer